ANL 24.19 Increased By ▲ 1.74 (7.75%)
ASC 15.20 Decreased By ▼ -0.76 (-4.76%)
ASL 22.00 Decreased By ▼ -0.40 (-1.79%)
BOP 8.42 Increased By ▲ 0.02 (0.24%)
BYCO 8.46 Decreased By ▼ -0.34 (-3.86%)
FCCL 17.40 Decreased By ▼ -0.51 (-2.85%)
FFBL 24.22 Decreased By ▼ -0.73 (-2.93%)
FFL 16.90 Decreased By ▼ -0.42 (-2.42%)
FNEL 8.15 Decreased By ▼ -0.08 (-0.97%)
GGGL 20.69 Decreased By ▼ -0.74 (-3.45%)
GGL 41.53 Increased By ▲ 0.33 (0.8%)
HUMNL 6.55 Decreased By ▼ -0.50 (-7.09%)
JSCL 20.13 Decreased By ▼ -0.22 (-1.08%)
KAPCO 37.50 Decreased By ▼ -0.46 (-1.21%)
KEL 3.51 Decreased By ▼ -0.04 (-1.13%)
MDTL 2.95 Decreased By ▼ -0.04 (-1.34%)
MLCF 35.05 Decreased By ▼ -1.62 (-4.42%)
NETSOL 144.85 Decreased By ▼ -6.55 (-4.33%)
PACE 5.97 Increased By ▲ 0.12 (2.05%)
PAEL 30.09 Decreased By ▼ -1.01 (-3.25%)
PIBTL 9.17 Decreased By ▼ -0.14 (-1.5%)
POWER 7.60 Decreased By ▼ -0.31 (-3.92%)
PRL 19.25 Decreased By ▼ -1.00 (-4.94%)
PTC 10.12 Decreased By ▼ -0.22 (-2.13%)
SILK 1.62 Decreased By ▼ -0.09 (-5.26%)
SNGP 43.50 Decreased By ▼ -1.17 (-2.62%)
TELE 22.00 Decreased By ▼ -0.20 (-0.9%)
TRG 170.50 Decreased By ▼ -4.10 (-2.35%)
UNITY 33.94 Decreased By ▼ -1.66 (-4.66%)
WTL 3.09 Decreased By ▼ -0.09 (-2.83%)
BR100 4,858 Decreased By ▼ -102.6 (-2.07%)
BR30 23,865 Decreased By ▼ -557.81 (-2.28%)
KSE100 46,009 Decreased By ▼ -519.36 (-1.12%)
KSE30 18,179 Decreased By ▼ -243.05 (-1.32%)

Coronavirus
HIGH Source: covid.gov.pk
Pakistan Deaths
27,327
8124hr
Pakistan Cases
1,227,905
1,89724hr
4.1% positivity
Sindh
451,448
Punjab
423,670
Balochistan
32,772
Islamabad
104,348
KPK
171,589

AstraZeneca

AstraZeneca expects US trial results in next 4-6 weeks
World

AstraZeneca expects US trial results in next 4-6 weeks

  • "I think we're getting very close to getting data. I would say in the next four to six weeks we should have the results for that study reading out,"
  • Some experts had expected the data sooner than that, given the high infection rates in the United States during the period of testing.
Published 05 Feb, 2021 08:46pm
Sinopharm vaccine not suitable for people above 60, pregnant women: SAPM Dr. Faisal Sultan
World

Sinopharm vaccine not suitable for people above 60, pregnant women: SAPM Dr. Faisal Sultan

  • According to the country's top health authorities, the Chinese manufactured Sinopharm vaccine is not suitable and recommended for people above the age of 60, under the age of 18, and specifically for pregnant women - among others.
  • According to Dr. Faisal Sultan, Special Assistant to the Prime Minister, people above 60 would be vaccinated with Oxford-AstraZeneca’s vaccine AZD1222, which is due for arrival in Pakistan in February.
Published 04 Feb, 2021 01:57pm
Pakistan to receive 17.2 million COVID-19 doses through COVAX
Pakistan

Pakistan to receive 17.2 million COVID-19 doses through COVAX

  • The distribution list includes doses of the AstraZeneca-Oxford vaccine, licensed to the Serum Institute of India, Pfizer-BioNTech vaccine and AstraZeneca-Oxford vaccine.
  • The distribution aims to cover an average of 3.3% of total population of 145 countries by mid-2021.
Published 04 Feb, 2021 11:44am
Vaccine storm engulfs EU chief von der Leyen
World

Vaccine storm engulfs EU chief von der Leyen

  • Several European diplomats in Brussels said the commission president's widely reported tendency to rely on a small number of trusted aides had let her down in such a complex crisis.
Published 03 Feb, 2021 09:50am